StockData
Clene Inc. logo

Clene Inc. (CLNN) income statement

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.42+0.20 (+6.21%)

Close on Nov 18, 2026Market cap $43.94MP/E –Yield –

Clene Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
70.1%
Operating margin
-10432.0%
Net margin
-20059.9%
Return on equity, FY2025
197.9%

Financial strength

Current ratio
3.07
Debt to equity
-0.22
Debt to assets
23.3%
Cash to current liabilities
199.3%

Valuation

P/E ratio
–
Price to sales
223.06
Price to book
–
Dividend yield
–

See a number that looks wrong?